Skip to main content

114 Role of Vaccine-induced V2 Antibodies in Protection From HIV Infection of Recipients in the RV144 Clinical Vaccine Trial

Publication ,  Conference
Zolla-Pazner, S; Williams, C; deCamp, A; Morris, D; Haynes, B; Kim, J; Michael, N; Rao, M
Published in: JAIDS Journal of Acquired Immune Deficiency Syndromes
April 2012

Duke Scholars

Published In

JAIDS Journal of Acquired Immune Deficiency Syndromes

DOI

ISSN

1525-4135

Publication Date

April 2012

Volume

59

Issue

Supplement 1

Start / End Page

46 / 46

Publisher

Ovid Technologies (Wolters Kluwer Health)

Related Subject Headings

  • Virology
  • 4206 Public health
  • 4202 Epidemiology
  • 3202 Clinical sciences
  • 1117 Public Health and Health Services
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Zolla-Pazner, S., Williams, C., deCamp, A., Morris, D., Haynes, B., Kim, J., … Rao, M. (2012). 114 Role of Vaccine-induced V2 Antibodies in Protection From HIV Infection of Recipients in the RV144 Clinical Vaccine Trial. In JAIDS Journal of Acquired Immune Deficiency Syndromes (Vol. 59, pp. 46–46). Ovid Technologies (Wolters Kluwer Health). https://doi.org/10.1097/01.qai.0000413733.06987.08
Zolla-Pazner, Susan, Constance Williams, Allan deCamp, Daryl Morris, Barton Haynes, Jerome Kim, Nelson Michael, and Mangala Rao. “114 Role of Vaccine-induced V2 Antibodies in Protection From HIV Infection of Recipients in the RV144 Clinical Vaccine Trial.” In JAIDS Journal of Acquired Immune Deficiency Syndromes, 59:46–46. Ovid Technologies (Wolters Kluwer Health), 2012. https://doi.org/10.1097/01.qai.0000413733.06987.08.
Zolla-Pazner S, Williams C, deCamp A, Morris D, Haynes B, Kim J, et al. 114 Role of Vaccine-induced V2 Antibodies in Protection From HIV Infection of Recipients in the RV144 Clinical Vaccine Trial. In: JAIDS Journal of Acquired Immune Deficiency Syndromes. Ovid Technologies (Wolters Kluwer Health); 2012. p. 46–46.
Zolla-Pazner, Susan, et al. “114 Role of Vaccine-induced V2 Antibodies in Protection From HIV Infection of Recipients in the RV144 Clinical Vaccine Trial.” JAIDS Journal of Acquired Immune Deficiency Syndromes, vol. 59, no. Supplement 1, Ovid Technologies (Wolters Kluwer Health), 2012, pp. 46–46. Crossref, doi:10.1097/01.qai.0000413733.06987.08.
Zolla-Pazner S, Williams C, deCamp A, Morris D, Haynes B, Kim J, Michael N, Rao M. 114 Role of Vaccine-induced V2 Antibodies in Protection From HIV Infection of Recipients in the RV144 Clinical Vaccine Trial. JAIDS Journal of Acquired Immune Deficiency Syndromes. Ovid Technologies (Wolters Kluwer Health); 2012. p. 46–46.

Published In

JAIDS Journal of Acquired Immune Deficiency Syndromes

DOI

ISSN

1525-4135

Publication Date

April 2012

Volume

59

Issue

Supplement 1

Start / End Page

46 / 46

Publisher

Ovid Technologies (Wolters Kluwer Health)

Related Subject Headings

  • Virology
  • 4206 Public health
  • 4202 Epidemiology
  • 3202 Clinical sciences
  • 1117 Public Health and Health Services
  • 1103 Clinical Sciences